Monthly Archives: March 2016

Biothera Announces Presentations at Upcoming American Association for Cancer Research (AACR) Annual Meeting

EAGAN, MN — March 16, 2016 — Biothera Pharmaceuticals Inc. announced today that it will present five scientific posters at the American Association for Cancer Research (AACR) Annual Meeting April 16-20 in New Orleans. Three of the posters were selected for the high profile, late-breaking research sessions—sessions devoted to the newest, most exciting research of the year. Details of the presentations are as follows: Poster Presentations:...

Read More


Biothera Pharmaceuticals to Present its Phase 2 Cancer Immunotherapy Data at International Molecular Medicine Tri-Conference

EAGAN, MN — March 10, 2016 — Biothera Pharmaceuticals Inc. today will present data on its Phase 2 cancer immunotherapy Imprime PGG, the Company’s first-in-class, systemically administered beta glucan PAMP (Pathogen Associated Molecular Patterning molecule) at Cambridge Healthtech Institute’s Molecular Medicine Tri-Conference 2016, taking place at the Moscone Convention Center, San Francisco. Jeremy Graff, Ph.D., Chief Scientific Officer and Senior Vice President, Research at Biothera...

Read More